Clinical Quality Assurance Specialist

Most weeks tend to involve site audits, document QA, vendor assessments, and inspection prep — traveling to investigator sites for audit visits, reviewing protocol deviations across active studies, conducting CRO or laboratory qualification audits, sitting on inspection-readiness teams. Audits completed, findings closed, and inspection performance are how progress shows up.

The harder part often lies in the multi-stakeholder dynamic — investigator sites, CROs, internal clinical teams, regulators, all with different priorities and pressure points. Variance across employers is wide: large pharma carries dedicated trial-stage QA teams; small biotechs concentrate the work in fewer practitioners who span more studies.

This work tends to suit folks who enjoy the detective work of audits and the patience of document review. SOCRA, ACRP, RAC, and growing FDA-inspection experience anchor seniority. The trade-off is the travel that site auditing requires and the emotional weight of work that supports drug or device development whose outcomes matter for patients.